Table 1.
Characteristic | LMI (n = 127) | HI (n = 128) |
---|---|---|
Study site, n (%) | ||
Linköping | 30 (24) | 24 (19) |
Lund | 56 (44) | 54 (42) |
Uppsala | 41 (32) | 50 (39) |
Age, years, mean (SD) | 53 (10) | 55 (11) |
Living with a partner, n (%) | 99 (78) | 95 (74) |
Completed university, n (%) | 90 (71) | 83 (65) |
Sick-leave, n (%) | ||
100% sick-leave | 49 (39) | 46 (36) |
75, 50, or 25% sick-leave | 7 (6) | 9 (7) |
Weight status, n (%) | ||
BMI – normal (18.5–24.9) | 65 (51) | 77 (60) |
BMI – overweight (25–29.9) | 49 (39) | 32 (25) |
BMI – obesity (≥ 30) | 13 (10) | 19 (15) |
Current smoker, n (%) | 6 (2) | 0 (0) |
Treatment, n (%) | ||
Chemotherapy | 89 (70) | 84 (66) |
No chemotherapy | 38 (30) | 44 (34) |
EORTC QLQ C30, mean (SD) | ||
Global health status/QoL | 61 (19) | 64 (20) |
Physical function | 87 (14) | 89 (13) |
Physical fatigue, MFI, mean (SD) | 12 (4) | 12 (4) |
Kinesiophobia, mean (SD) | 23 (5) | 23 (5) |
MVPA, hours/day, mean (SD) | 1.3 (1.0) | 1.3 (0.9) |
VO2peak (ml/kg/min), mean (SD) | 31.3 (7.1) | 31.5 (7.3) |
BMI, body mass index; EORTC QLQ C30, European Organization for Research and Treatment of Cancer, quality of life of cancer patients; QoL, quality of life; MFI, Multidimensional Fatigue Inventory; Tampa, The Tampa Scale of Kinesiophobia; MVPA, moderate- to vigorous-intensity physical activity; VO2peak, peak oxygen uptake (ml per kilogram per min).